Astral Foods Limited Overview
Astral Foods is South Africa's largest vertically integrated poultry producer. By its own estimate it held about 27% of local broiler production in H1 FY2026, slaughtering about 6.1 million birds per week from a national total of about 22.3 million [S5]. The group controls the full chain:
-
Ross 308 broiler genetics through Ross Poultry Breeders
-
Day-old chick supply through National Chicks
-
Feed milling through Meadow Feeds' seven mills
-
Breeder and broiler farming
-
Abattoir and further processing
-
Branded sales under Goldi, County Fair, Festive, Mountain Valley and Earlybird
Its stated strategy is to be the best-cost integrated poultry producer in selected Southern African countries [S5]. The model is highly operationally geared to two variables: feed raw-material costs (feed is about 66% of broiler live cost) and chicken selling prices [S1]. That gearing explains the sharp swing in profit:
The balance sheet now holds net cash, which the company says can fund growth.
Company's own description
In its FY2025 results, Astral describes itself as a leading South African integrated poultry producer. Its listed key activities are:
-
Animal feed manufacturing
-
Broiler genetics
-
Production and sale of day-old chicks and hatching eggs
-
Integrated breeder and broiler production
-
Abattoirs
-
Sale and distribution of its poultry brands [S1]
The corporate website and results presentations state the strategy as being the best-cost integrated poultry producer in selected Southern African countries. Management reconfirmed this strategy in February 2025 [S5].
Independent characterisation
Astral is effectively a commodity-conversion business. It converts maize and soya into chicken protein through a closed genetics-to-plate chain. Value is created mainly in four ways:
Feed conversion efficiency: Chicken has a feed conversion ratio of about 1.4, versus 2.2 for pork and 5.5 for beef, per industry data presented by Astral [S5].
Fixed-cost absorption: Running abattoirs and feed mills at maximum throughput spreads fixed overheads.
Product and channel mix: The mix across IQF, fresh, quick-service restaurant (QSR) and value-added products drives realised prices.
Self-supply of inputs: Internal supply of genetics and feed captures the feed-mill margin and protects biosecurity.
The weak points are pricing power and infrastructure:
-
Broiler selling prices are set by a market where imports supplied about 26% of local consumption in H1 FY2026 [S5].
-
Retail promotional intensity also limits pricing.
-
The business carries high exposure to municipal water and electricity reliability, as shown by the FY2023 loadshedding crisis and the long-running Standerton (Lekwa) dispute [S2][S25].
Business and revenue model
| Revenue stream | Model | Approximate share |
|---|---|---|
| Poultry products (IQF, fresh, frozen, value-added, tertiary/offal) | Product sales to retailers, QSR, wholesale and informal trade | Poultry Division: 82.5% of external revenue (FY2025) |
| Day-old chicks, hatching eggs, parent stock (Ross 308) | Product sales to external broiler producers; also supplied internally | Within Poultry Division. Breeder revenue grew 24.3% in H1 FY2026; absolute value not disclosed. |
| Animal feeds (poultry, layer, pig, dairy, sheep and other livestock) | Product sales. Prices are largely set on a raw-material cost pass-through basis. | Feed Division: 17.5% of external revenue (FY2025) |
| Laboratory analytics (Central Analytical Laboratories) | Fee-for-service | Not separately disclosed; immaterial |
| Feed delivery service | Delivery fee charged to feed customers | Not separately disclosed. Delivery costs were reclassified into cost of sales in FY2024. |
Sources: [S1][S2][S5].
The revenue mix is essentially 100% product sales. There are no subscription or licensing revenues of note. The Ross 308 business is a genetics distribution franchise: Ross is an Aviagen breed, and Astral's Ross Poultry Breeders supplies Ross 308 breeding stock to the South African industry [S38].
Value-chain position and cost structure
| Ingredient | Share of inclusion | Share of cost |
|---|---|---|
| Maize | About 59% | About 38% |
| Soya meal | About 17% | About 20% |
| Extruded soya | About 13% | About 17% |
Astral spans every stage from feed raw-material procurement to branded distribution. Its broiler feed formulation in H1 FY2026, presented by the company, breaks down as follows [S5]:
Feed cost represented about 66% of the live cost of a broiler in FY2025, about 65% in FY2024 and about 70% in FY2022 [S1][S2][S3].
Customer types and end markets
| Category | Share of volume |
|---|---|
| IQF mixed portions | About 49–51% |
| Tertiary products | About 21–22% |
| Fresh | About 13% |
| Value-added | About 7% |
| IQF single portions | About 5–6% |
| Frozen | About 3% |
Poultry customers:
-
National retail chains (promotional frozen and IQF categories)
-
QSR chains (fresh and QSR cuts, a stated growth channel)
-
Wholesalers and informal-trade distributors
-
External broiler producers buying parent stock and day-old chicks
Feed customers:
-
Integrated poultry (internal)
-
External poultry, including commercial layer and table-egg producers
-
Pig, dairy, sheep and beef producers
-
Zambian livestock producers, through Tiger Animal Feeds
Named customers and customer-concentration percentages are not publicly disclosed [S1][S4][S5].
Poultry sales mix, H1 FY2026 (approximate, read from the company's chart; total about 261,875 t versus about 259,181 t, volume up about 1%) [S5]:
Strategy
Stated strategy
Management reconfirmed in February 2025 that the strategy is to be the "best cost integrated poultry producer" in selected Southern African countries [S5]. In the FY2025 and H1 FY2026 outlook sections the strategy rests on four pillars [S1][S4]:
-
Volume. Run broiler production at maximum available capacity to dilute fixed costs and support retail and QSR growth.
-
Efficiency. Pursue production efficiencies through a company-wide cost-awareness campaign.
-
Innovation. Invest in process and product innovation to strengthen manufacturing capability and product mix.
-
Capital deployment. Use the healthy balance sheet for strategic investment in efficiency, expansion of manufacturing capability and "growth opportunities".
Initiatives in the last 24 months
| Initiative | Date | Description / targets | Source |
|---|---|---|---|
| Project 3R (Re-set, Re-focus, Re-start) | FY2024 | Turnaround after FY2023; management says all controllable metrics performed well | [S2] |
| Leadership succession | November 2024 – March 2026 | New CEO (Arnold) and new CFO (Geel); board refreshed with three new independent directors | [S14][S11][S15][S16] |
| Broiler capacity optimisation | FY2025 – H1 FY2026 | Throughput rose from 5.4 m (FY2024) to 5.8 m (FY2025) and about 6.1 m birds/week (H1 FY2026); guided to stay at maximum available capacity | [S1][S4][S5] |
| HPAI vaccination programme | July 2025 onward | First permit (Gauteng farm, about 5% of breeders); two Mpumalanga farms approved in November 2025; five large breeder farms (about 30% of breeding stock) vaccinated by May 2026 using an H5 vaccine from an international manufacturer | [S22][S23][S5] |
| Capex programme | FY2025 – FY2026 | FY2025 capex R336 m (+20.9%). H1 FY2026 capex R205 m (replacement R157 m; expansion R48 m); outstanding commitments R112 m | [S1][S5] |
| Product innovation | 2025–2026 | Earlybird Southern Style Crumbed Chicken range; growth in value-added and fresh categories | [S38] |
| Infrastructure resilience | FY2020 – FY2024 | R50 m reverse-osmosis plant at Standerton (FY2020); R168 m spent on generators and water contingencies (FY2023) | [S25][S2] |
| Dividend resumption | FY2024 – FY2026 | Final 520 ZAc (FY2024); total 1,100 ZAc (FY2025); interim 1,160 ZAc (H1 FY2026) at about 2x headline earnings cover | [S1][S2][S5] |
| Poultry Sector Master Plan, Phase 2 | Signed before May 2026 | Industry–government plan to support local production, keep current import trade measures and create export opportunities | [S4] |
| Competition Commission Poultry Market Inquiry engagement | October 2025 onward | Cooperating directly and through SAPA | [S24] |
| Continuous-improvement programme ("20 Keys" conference) | 17 September 2026 | Internal operational-excellence conference; scope not disclosed | [S40] |
| ESG commitments | — | Quantified emissions or water targets are not publicly disclosed in the documents reviewed | — |
Medium-term financial targets and guidance
Not publicly disclosed. Astral gives qualitative outlook factors, not numeric guidance, and uses JSE trading statements (EPS/HEPS ranges) shortly before results. The only explicit capital-allocation parameter is an interim dividend at 2x cover (H1 FY2026) [S5].
Products & Services
Poultry Division — consumer and foodservice brands
| Brand | Description and positioning | Target customer / channel | Key capabilities | Launch / latest | Pricing |
|---|---|---|---|---|---|
| Goldi | National mass-market chicken brand. Associated with the Standerton (Mpumalanga) integrated operation, supplied by Meadow Feeds Standerton and Delmas. Contributed about R3.4 bn of revenue in 2013. | National retail and wholesale, mass market | Frozen and IQF portions, whole birds, fresh in selected regions | Long-standing; current-year relaunch not disclosed | Not disclosed (market-driven) |
| County Fair | Leading fresh chicken supplier in the Western Cape; nationwide supplier of frozen and value-added products. Feed comes from Meadow Feeds Paarl. | Western Cape retail (fresh); national retail (frozen and value-added) | Fresh, frozen and value-added ranges | Long-standing | — |
| Festive | Fresh portioned chicken for Gauteng and the Free State. FY2022 broiler volume growth was attributed to the "Festive expansion". | Gauteng and Free State retail, fresh category | Fresh portions | Capacity expansion delivered by FY2022 | — |
| Mountain Valley | Regional brand sold only in KwaZulu-Natal; fresh and processed chicken. Feed from Meadow Feeds Pietermaritzburg. Camperdown plant was about 150,000 birds/week in 2013. | KwaZulu-Natal retail | Fresh and processed | Long-standing | — |
| Earlybird | Brand used for value-added and foodservice lines. The current flagship is the Earlybird Southern Style Crumbed Chicken range; historically also Earlybird Catering. Also the name of the integrated operations at Standerton and Olifantsfontein. | Retail value-added freezer; foodservice | Crumbed and coated value-added products | Southern Style range promoted on the current website (launch year not disclosed) | — |
| SupaStar | Listed by third-party profiles as an Astral product brand; not shown on the current corporate brand page | — | — | — | — |
| QSR supply (unbranded / customer-specified) | Fresh and QSR cut specifications for quick-service restaurant chains; a stated strategic growth channel since FY2022 | QSR chains (customers not named) | Specification portioning, fresh supply | Ongoing expansion | Contract pricing, not disclosed |
Product formats (the Poultry Commercial sales-mix taxonomy) [S5]:
IQF mixed portions: the largest category, about half of volume.
IQF single portions: - Frozen.
Fresh: about 13%.
Value-added: about 7%.
Tertiary: offal and by-products, about 21–22%. This category faced price pressure from imported offal in H1 FY2026.
Poultry Division — Agriculture (genetics, chicks, breeding)
| Brand / unit | Description | Target customer | Key capabilities / specifications | Latest data point |
|---|---|---|---|---|
| Ross Poultry Breeders | Supplier of Ross 308 broiler breeder stock to the South African industry | Integrated and independent broiler producers | Ross 308 genetics (an Aviagen breed); parent stock sales | Parent-stock sales rose in H1 FY2026 as some customers expanded placements [S5] |
| National Chicks | One of the leading suppliers of day-old chicks to the industry | Independent and emerging broiler farmers; internal supply | Hatcheries, day-old broilers, hatching eggs | Breeder revenue +24.3% in H1 FY2026 [S5] |
| Broiler breeder and broiler farming | Breeder farms and broiler growing for the integrated chain; about 37 m birds on farm at any time | Internal | All-time-high on-farm performance efficiency factor (PEF) in H1 FY2026; five large breeder farms (about 30% of breeding stock) vaccinated against HPAI | [S5][S36] |
| Tiger Chicks (Zambia) | Day-old chick business in Zambia; describes itself as the first slow-feathering broiler bred in Africa | Zambian broiler farmers | Local breed | [S38] |
Feed Division
| Brand / unit | Description | Target customer | Key capabilities | Latest data point |
|---|---|---|---|---|
| Meadow Feeds | Positioned by the company as the southern African feed market leader; claims to be the largest feed company in Africa. Seven mills with automated batching and control systems. | Internal integrated poultry; external poultry (broiler, layer, breeder), pig, dairy, sheep and beef producers | Complete feeds, technical advisory (nutrition, feeding programmes, husbandry); historically linked to the Provimi/Nutec premix business | Total feed volumes +7.0% in FY2025; +9.8% in H1 FY2026 to 751,792 t [S1][S5] |
| Tiger Animal Feeds (Zambia) | Leading feed supplier in Zambia for more than ten years | Zambian livestock and poultry producers | Feed manufacturing | "Much improved" in FY2025; strong earnings growth in H1 FY2026 [S1][S4] |
| Central Analytical Laboratories (CAL) | Analytical services to the animal feed and poultry industry, its suppliers and customers | Feed industry (third parties and internal) | Feed and raw-material analysis | Revenue not disclosed [S38] |
Pricing model. Feed is priced largely on a cost-plus basis linked to SAFEX yellow maize and Durban soya meal input costs. In H1 FY2026, average feed selling prices fell 9.8% as maize fell 31% [S5]. Poultry prices are market-determined and heavily influenced by retail promotions and import parity. Breeder and chick pricing is not disclosed.
Financial Narrative
Basis of preparation:
-
FY2021–FY2022 figures come from the FY2022 audited summarised results. FY2021 is re-presented there for discontinued operations (Mozambique and the eSwatini JV) [S3].
-
FY2023–FY2024 figures come from the FY2024 audited summarised results, with FY2023 restated for the cost-of-sales reclassification [S2].
-
FY2025 figures come from the FY2025 audited summarised results [S1].
-
EBITDA is derived as PBIT plus depreciation and amortisation, including right-of-use (lease) amortisation.
Income statement
Sources: [S1][S2][S3].
Notes on the table:
-
FY2021 revenue growth is derived from FY2020 revenue of about R14,104 m, taken from the company's six-monthly revenue chart [S5].
-
FY2023 D&A uses the note 4 components (R315.5 m). The segment table shows R310.2 m.
-
The FY2021 operating margin computed here is 4.5%. Management's stated 4.6% includes discontinued operations.
Margins
Derived from [S1][S2][S3].
Balance sheet
Sources: [S1][S2][S3].
Notes on the table:
-
A negative net debt figure means net cash.
-
FY2023 borrowings include a R600 m ABSA working-capital loan, repaid in FY2024 [S2].
-
Net asset value per share as reported by the company: R122.38 (FY2024) and R139.50 (FY2025) [S1]. The company's share-count basis for NAV is not consistent across years, so a five-year NAV series is not presented.
Latest interim balance sheet (31 March 2026) [S4]:
-
Total assets R9,893.6 m; equity R5,977.4 m.
-
Cash R1,152.3 m; borrowings nil; lease liabilities R256.5 m. Net cash including leases: R895.8 m (derived).
-
Net working capital R2,404 m (company definition).
Cash flow
Sources: [S1][S2][S3].
Notes on the table:
-
Free cash flow equals operating cash flow after tax minus cash capex. It is before lease repayments.
-
Management's stated total capex, including accruals, was R398 m (FY2023), R278 m (FY2024) and R336 m (FY2025).
H1 FY2026 cash flow [S4]:
Ratios
All values derived from [S1][S2][S3].
Notes on the table:
Net invested capital: is equity plus borrowings plus leases minus cash.
FY2023 net debt to EBITDA and interest coverage: are arithmetically negative because EBITDA and PBIT were negative. They are not meaningful.
Working-capital days: use trade and other receivables and payables, so they are approximations.
Commentary — trends, inflections and drivers
FY2021 (recovery off the COVID-19 and feed-cost trough). Revenue grew 12.5% to R15.9 bn. Poultry operating profit was only R147 m (1.1% margin), while the Feed Division earned R530 m [S3]. The group paid R418 m of dividends, close to free cash flow. Lease amortisation of R208 m was unusually high, which inflates FY2021 EBITDA.
FY2022 (cyclical peak). Revenue rose 21.9% to R19.3 bn. Broiler sales realisations were up 12.5%, slaughter volumes up 7.7% on the Festive expansion, and QSR and fresh mix improved. Operating margin rose to 7.4% and ROE peaked at 23.9%. HEPS reached a record 2,762 ZAc, and the total dividend was 1,380 ZAc [S3]. Management warned at the time of record feed costs, loadshedding and municipal decay; that warning proved correct.
FY2023 (crisis year).
The broiler net margin fell to -9.7%. Astral recorded its first operating loss (-R621 m), operating cash flow of -R971 m, and net debt including leases of R1.3 bn. It raised a R600 m ABSA facility. Dividends were suspended after the FY2022 final payment [S2][S34].
FY2024 (turnaround). Project 3R restored profitability. Operating profit was R1,125 m, helped by R251.6 m of insurance recoveries; the broiler net margin was 1.3%. The overdraft was cleared, the ABSA loan repaid, and banking facilities were renegotiated as unsecured with no covenants. A final dividend of 520 ZAc was declared [S2].
FY2025 (normalisation, then second-half acceleration). H1 was weak, with selling-price deflation and a broiler margin of -1.1%. H2 was strong, with a broiler margin of +3.9% and volumes of 5.8 m birds/week. Excluding insurance, operating profit rose 42.8%, and Feed reached a record R714 m [S1]. Working capital released R276 m and year-end cash exceeded R1 bn.
H1 FY2026 (inflection). The operating margin reached 10.2%. Drivers were:
-
Lower maize prices: SAFEX yellow maize averaged R3,470/t versus R5,004/t, down 31%.
-
Broiler realisations up 9.5%.
-
Production of 6.1 m birds/week, improving fixed-cost recovery.
-
Record on-farm performance.
H1 FY2026 EPS of 2,321 ZAc already exceeds full-year FY2025 EPS of 2,276 ZAc [S4][S5]. The structural takeaway is high operating gearing. On management's H1 PBIT bridge, broiler selling price contributed about R777 m and lower broiler raw-material cost about R317 m of the R943 m PBIT improvement; volume and other items accounted for the rest [S5].
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Results by Segment and Segment Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Poultry segment revenue incl. inter-segment (ZAR Mn) | 15,833.3 | 17,055.8 | 18,818.5 |
Feed segment revenue incl. inter-segment (ZAR Mn) | 11,588.9 | 9,865.7 | 10,788.6 |
Inter-segment eliminations (ZAR Mn) | -8,171.2 | -6,440.7 | -6,988.0 |
Poultry segment operating profit / PBIT (ZAR Mn) | -1,379.8 | 580.4 | 533.6 |
Feed segment operating profit / PBIT (ZAR Mn) | 758.9 | 544.5 | 713.8 |
Poultry operating margin on segment revenue (%) | -8.7 | 3.4 | 2.8 |
Feed operating margin on segment revenue (%) | 6.5 | 5.5 | 6.6 |
Poultry share of external revenue (%) | 81.5 | 82.6 | 82.5 |
Feed share of external revenue (%) | 18.5 | 17.4 | 17.5 |
Poultry segment revenue growth YoY (%) | 0.0 | 7.7 | 10.3 |
Feed segment revenue growth YoY (%) | 15.7 | -14.9 | 9.4 |
Poultry gross profit (ZAR Mn) | 410.4 | 2,503.5 | 2,724.0 |
Feed gross profit (ZAR Mn) | 1,455.4 | 987.3 | 1,240.2 |
Poultry capex on PPE (ZAR Mn) | 282.4 | 167.0 | 278.4 |
Feed capex on PPE (ZAR Mn) | 109.6 | 110.4 | 57.3 |
Poultry depreciation and amortisation (ZAR Mn) | 253.7 | 262.8 | 270.0 |
Feed depreciation and amortisation (ZAR Mn) | 56.1 | 58.5 | 60.5 |
Results by Segment
| Metric | 1H2023 | 2H2023 | 1H2024 | 2H2024 | 1H2025 | 2H2025 | 1H2026 |
|---|---|---|---|---|---|---|---|
Group external revenue (ZAR Mn) | 9,964 | 9,287 | 10,362 | 10,118 | 10,721 | 11,898 | 11,944 |
Group operating profit (ZAR Mn) | 98 | -719 | 550 | 575 | 271 | 976 | 1,214 |
Poultry operating profit (ZAR Mn) | -283 | -1,097 | 284 | 297 | -26 | 559 | 848 |
Feed operating profit (ZAR Mn) | 381 | 378 | 266 | 278 | 297 | 417 | 366 |
Revenue by Segment and Segment Margins & Growth (%)
| Metric | H1 FY2025 | H1 FY2026 |
|---|---|---|
Poultry segment revenue (ZAR Mn) | 8,838.1 | 10,072.7 |
Feed segment revenue (ZAR Mn) | 5,313.0 | 5,316.1 |
Poultry PBIT (ZAR Mn) | -26.0 | 847.8 |
Feed PBIT (ZAR Mn) | 297.0 | 365.8 |
Poultry PBIT margin (%) | -0.3 | 8.4 |
Feed PBIT margin (%) | 5.6 | 6.9 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (ZAR Mn) | 15,865.9 | 19,333.9 | 19,251.0 | 20,479.8 | 22,619.2 |
Revenue growth (%) | 12.5 | 21.9 | -0.4 | 6.4 | 10.4 |
Cost of sales (ZAR Mn) | 13,025.0 | 15,310.5 | 17,718.6 | 16,989.0 | 18,655.0 |
Gross profit (ZAR Mn) | 2,841.0 | 4,023.3 | 1,532.3 | 3,490.8 | 3,964.2 |
Operating profit / PBIT (ZAR Mn) | 711.0 | 1,439.8 | -620.9 | 1,124.9 | 1,247.4 |
Depreciation and amortisation incl. ROU (ZAR Mn) | 421.8 | 306.8 | 315.5 | 321.3 | 330.7 |
EBITDA, derived (ZAR Mn) | 1,132.8 | 1,746.6 | -305.4 | 1,446.2 | 1,578.1 |
Net finance cost (ZAR Mn) | -48.7 | -14.7 | -76.2 | -101.1 | -36.0 |
Profit before tax (ZAR Mn) | 662.3 | 1,425.1 | -697.1 | 1,023.8 | 1,211.4 |
Tax (ZAR Mn) | -202.7 | -370.5 | 184.9 | -270.9 | -335.0 |
Net profit incl. discontinued ops (ZAR Mn) | 473.7 | 1,070.6 | -512.2 | 752.9 | 876.4 |
Net profit attributable to shareholders (ZAR Mn) | 472.5 | 1,068.4 | -512.2 | 752.9 | 876.4 |
Headline earnings (ZAR Mn) | 473.7 | 1,061.3 | -508.5 | 738.2 | 844.5 |
Basic EPS (ZAc) | 1,225 | 2,781 | -1,333 | 1,959 | 2,276 |
Diluted EPS (ZAc) | 1,217 | 2,751 | -1,333 | 1,939 | 2,257 |
HEPS (ZAc) | 1,228 | 2,762 | -1,324 | 1,920 | 2,193 |
Diluted HEPS (ZAc) | 1,220 | 2,733 | -1,324 | 1,901 | 2,175 |
Dividends declared per share (ZAc) | 700 | 1,380 | 0 | 520 | 1,100 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 17.9 | 20.8 | 8.0 | 17.0 | 17.5 |
Operating (PBIT) margin (%) | 4.5 | 7.4 | -3.2 | 5.5 | 5.5 |
EBITDA margin (%) | 7.1 | 9.0 | -1.6 | 7.1 | 7.0 |
Net margin (%) | 3.0 | 5.5 | -2.7 | 3.7 | 3.9 |
Effective tax rate (%) | 30.6 | 26.0 | 26.5 | 26.5 | 27.7 |
CAGR by Period
| Period | CAGR | Basis |
|---|---|---|
FY2021–FY2025 (4 years) | 9.3% | Derived |
FY2020–FY2025 (5 years) | About 9.9% | Derived, using FY2020 revenue of about R14,104 m from the company chart [S5] |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (ZAR Mn) | 7,835.0 | 8,438.3 | 9,110.7 | 9,097.8 | 9,325.8 |
Cash and cash equivalents (ZAR Mn) | 668.5 | 723.4 | 713.4 | 739.2 | 1,040.5 |
Bank overdraft and short-term borrowings (ZAR Mn) | 390.8 | 22.3 | 1,744.1 | 751.6 | 28.0 |
Long-term borrowings (ZAR Mn) | 0 | 0 | 0 | 0 | 0 |
Lease liabilities, total (ZAR Mn) | 376.5 | 309.7 | 272.0 | 183.5 | 293.9 |
Net debt incl. leases, derived (ZAR Mn) | 98.8 | -391.4 | 1,302.7 | 195.9 | -718.6 |
Net debt excl. leases, derived (ZAR Mn) | -277.7 | -701.1 | 1,030.7 | 12.4 | -1,012.5 |
Total equity (ZAR Mn) | 4,161.2 | 4,786.0 | 4,019.5 | 4,752.4 | 5,374.6 |
Goodwill and intangibles (ZAR Mn) | 186.1 | 162.5 | 162.6 | 157.9 | 154.2 |
Inventories (ZAR Mn) | 921.1 | 1,178.5 | 1,895.2 | 1,553.4 | 1,024.9 |
Biological assets (ZAR Mn) | 976.3 | 1,245.9 | 1,047.6 | 1,331.4 | 1,401.1 |
Trade and other receivables (ZAR Mn) | 1,595.7 | 1,708.3 | 1,789.4 | 1,987.4 | 2,183.8 |
Trade and other payables (ZAR Mn) | 1,785.4 | 1,966.5 | 2,246.0 | 2,177.9 | 2,188.8 |
Working capital, current assets less current liabilities (ZAR Mn) | 1,691.9 | 2,373.7 | 1,159.5 | 2,241.1 | 2,948.5 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash operating profit (ZAR Mn) | 1,155.8 | 1,905.7 | -600.6 | 1,677.6 | 1,527.7 |
Change in working capital (ZAR Mn) | -343.6 | -413.4 | -323.2 | -221.5 | 276.3 |
Cash flow from operating activities after tax (ZAR Mn) | 676.4 | 1,197.9 | -970.8 | 1,394.5 | 1,677.3 |
Capex, cash: PPE plus intangibles (ZAR Mn) | 259.5 | 280.8 | 373.6 | 268.2 | 328.2 |
Free cash flow, derived (ZAR Mn) | 417.0 | 917.1 | -1,344.4 | 1,126.3 | 1,349.0 |
Dividends paid (ZAR Mn) | 418.2 | 457.7 | 226.0 | 0 | 284.9 |
Lease principal repayments (ZAR Mn) | 204.6 | 89.7 | 82.1 | 100.6 | 80.1 |
Treasury shares bought for share plan (ZAR Mn) | 24.9 | 26.8 | 13.3 | 28.4 | 12.9 |
Share buybacks for cancellation (ZAR Mn) | 0 | 0 | 0 | 0 | 0 |
Financial Analysis
| Item | ZAR Mn |
|---|---|
Cash operating profit | 1,476.3 |
Working capital outflow | -418.1 |
Tax paid | -356.7 |
Operating cash flow | 701.5 |
PPE capex (replacement R157 m; expansion R48 m) | -226.3 |
Dividends paid | -341.6 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE on average equity (%) | 11.4 | 23.9 | -11.6 | 17.2 | 17.3 |
ROA on year-end assets (%) | 6.0 | 12.7 | -5.6 | 8.3 | 9.4 |
ROIC, NOPAT at 27% tax over net invested capital (%) | 12.2 | 23.9 | -8.5 | 16.6 | 19.6 |
Current ratio (x) | 1.66 | 1.94 | 1.27 | 1.66 | 2.09 |
Debt to equity incl. leases (x) | 0.18 | 0.07 | 0.50 | 0.20 | 0.06 |
Net debt to EBITDA incl. leases (x) | 0.09 | -0.22 | -4.27 | 0.14 | -0.46 |
Interest coverage, PBIT over gross finance costs (x) | 11.6 | 32.6 | -5.7 | 8.0 | 22.8 |
Asset turnover, revenue over year-end assets (x) | 2.03 | 2.29 | 2.11 | 2.25 | 2.43 |
Days inventory incl. biological assets (days) | 53.2 | 57.8 | 60.6 | 62.0 | 47.5 |
Days sales outstanding (days) | 36.7 | 32.3 | 33.9 | 35.4 | 35.2 |
Days payables outstanding (days) | 50.0 | 46.9 | 46.3 | 46.8 | 42.8 |
Cash conversion cycle (days) | 39.9 | 43.2 | 48.2 | 50.6 | 39.9 |
Driver Details
| Driver | Cost |
|---|---|
Additional feed for older, heavier birds during the loadshedding-induced slaughter backlog | R1,059 m |
Diesel and generator costs | R425 m |
Down-placements | R170 m |
HPAI (H7N6) biological asset write-downs | R400 m |
Insurance recoveries (offset) | R127 m |
Revenue by Region
| Metric | FY2021 | FY2022 |
|---|---|---|
Other Africa revenue, continuing ops (ZAR Mn) | 289.4 | 470.6 |
Other Africa operating profit, continuing ops (ZAR Mn) | 34.6 | 64.9 |
Discontinued ops revenue, Mozambique and eSwatini JV (ZAR Mn) | 181.3 | 125.8 |
Discontinued ops PBIT (ZAR Mn) | 20.4 | 17.7 |
Share Price History
| Date | Price (ZAR) | Context |
|---|---|---|
18 July 2013 | Market cap about R3.9 bn | Historical reference |
5 May 2025 | 166.06 | After the H1 FY2025 trading statement (-5.1% on the day) |
24 August 2025 | 200.84 | Pre-FY2025 results |
16 February 2026 | 279.98 | Near the 52-week high; 1-year return about +60% at that date |
24 July 2026 | 206.55 | — |
2 September 2026 | 199.00 | YTD -25.38%; 3 months -17.2%; 6 months -29.3% |
52-week high / low (to 2 September 2026) | 284.66 / 190.56 | — |
3-year and 5-year low (to 2 September 2026) | 131.27 | — |
10-year range (to 2 September 2026) | 110.79 – 335.19 | — |
Valuation Multiples
| Multiple | Astral (TTM to March 2026) | Astral (FY2025) | Rainbow Chicken (FY June 2026) | Quantum Foods |
|---|---|---|---|---|
P/E (x) | 4.8 | 8.7 | About 4.3 (R6.43 price at 28 August 2026; EPS 149.55c) | About 6.3 (R8.50 at December 2025; EPS 134.4c) |
P/headline earnings (x) | 4.9 | 9.1 | About 4.3 | Not computed |
EV/EBITDA (x) | 2.7 | 4.3 | — | Not computed |
EV/Sales (x) | 0.29 | 0.30 | Not computed | Not computed |
P/B (x) | 1.29 | 1.43 | Not computed | Not computed |
Dividend yield (%) | 10.3 (trailing 2,040 ZAc) | 5.5 (1,100 ZAc) | Not computed | Not computed |
Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Interim dividend (ZAc) | 300 | 790 | 0 | 0 | 220 |
Final dividend (ZAc) | 400 | 590 | 0 | 520 | 880 |
Total dividend (ZAc) | 700 | 1,380 | 0 | 520 | 1,100 |
Headline earnings cover (x) | 1.75 | 2.00 | 0 | 3.69 | 1.99 |
Capital Markets
| Item | Detail |
|---|---|
Share buybacks | No general repurchase programme announced. Treasury shares (about 4.09–4.21 m) are held by subsidiary Astral Operations Ltd. Forfeitable share plan purchases were R12.9 m (FY2025) and R18.4 m (H1 FY2026). |
Credit ratings (Moody's / S&P / Fitch) | None identified. Astral is not publicly rated and has no listed debt. |
Debt maturity profile | No borrowings at 31 March 2026. Lease liabilities R256.5 m: R120.3 m due within 12 months, R136.2 m beyond. Bank facilities are unsecured, covenant-free and have a long-dated notice period (renegotiated FY2024). |
Off-balance-sheet raw material commitments | R2,343 m (31 March 2026); R3,023 m (30 September 2025) |
Analyst Conclusions
Management guidance
Management gives no numeric guidance. The H1 FY2026 outlook is qualitative [S4][S5].
Positives cited:
-
Record 2025/26 grain harvest, expected to keep feed costs stable in the short term
-
Broiler volumes at maximum available capacity
-
Vaccination coverage for part of the breeding stock this winter
-
Balance sheet capacity for strategic investment
-
Signing of Poultry Master Plan Phase 2
Negatives cited:
-
Bird flu, given higher Northern Hemisphere infection rates
-
Middle East conflict lifting fuel and transport costs and squeezing consumers
-
Fertiliser and fuel costs weighing on primary agriculture
-
El Niño drought risk for 2026/27
-
Geopolitical, currency and commodity volatility
FY2026 expectation (analyst arithmetic, not guidance)
H1 FY2026 EPS of 2,321 ZAc already exceeds full-year FY2025 EPS of 2,276 ZAc [S4][S1]. For FY2026 EPS to rise less than 20% (below about 2,731 ZAc), H2 FY2026 EPS would need to fall below about 410 ZAc. H2 FY2025 EPS was 1,804 ZAc (derived).
A positive JSE trading statement for FY2026 is therefore highly probable around late October 2026, unless H2 suffered a major disruption that has not been disclosed.
If H2 FY2026 PBIT merely matched H2 FY2025 (R976 m), FY2026 PBIT would be about R2.19 bn, roughly 76% above FY2025. This is a scenario, not a forecast.
Consensus growth expectations are not publicly disclosed. MarketScreener implies modest revenue growth (EV/Sales 0.27x in 2026E falling to 0.24x in 2027E) [S20].
Bull case
-
Structural cost advantage at peak capacity. At about 6.1 m birds per week, fixed-cost absorption lifted the Poultry margin to 8.4% in H1 FY2026 from -0.3% [S4][S5]. With the 2026/27 maize stocks-to-use forecast at 21.65% [S5], feed costs could stay benign into FY2027.
-
Cheap valuation with a cash-rich balance sheet. The stock trades at about 4.8x TTM P/E and about 2.7x EV/EBITDA, with a 10.3% trailing yield and R1.15 bn of net cash [S4][S20]. Even a 50% earnings normalisation would leave the P/E below 10x.
-
Biosecurity moat. About 30% vaccinated breeding stock and first-mover permits [S5] lower the probability of a repeat of the FY2023 losses (R400 m of HPAI write-downs), while competitors may lag.
Bear case
-
Peak-cycle margins. The broiler net margin of 9.3% in H1 FY2026 is far above the 1.3–1.5% full-year averages of FY2024–FY2025 [S5][S1][S2]. History (FY2022 peak followed by the FY2023 loss) shows how fast margins can reverse.
-
Import pressure is building. Imports rose 39.7% to about 26% of consumption, 87.4% from Brazil [S5]. An oversupplied market plus stressed consumers could renew price deflation, as in H1 FY2025 when prices fell 3.1% [S6].
-
Weather and regulatory overhangs. El Niño could reverse the maize tailwind for 2026/27 [S4]. The Competition Commission inquiry could impose remedies on vertical integration, which is the core of Astral's model [S24].
Key catalysts and monitorables (next 12 months)
-
FY2026 trading statement (expected late October 2026) and audited FY2026 results (expected mid-November 2026); quality of H2 FY2026 earnings
-
FY2026 final dividend size and cover
-
Deployment of the R1.15 bn+ cash pile: capex step-up, acquisitions, or special distributions
-
Monthly SAPA import data, especially Brazilian frozen bone-in and offal volumes
-
SAFEX yellow maize prices and El Niño forecasts for the 2026/27 planting season
-
HPAI incidence during the Southern Hemisphere winter and expansion of vaccination permits beyond 30% of breeding stock
-
Competition Commission inquiry milestones (submissions, provisional findings)
-
Retail selling-price trends and consumer stress indicators (fuel prices, unemployment)
-
New CFO's first full-year reporting and any capital-allocation framework
-
Board committee reconstitution after the August 2026 appointments
Concluding analyst verdict
| Indicator | Value |
|---|---|
| Net cash | R1.15 bn |
| Borrowings | — |
| H1 FY2026 operating margin | 10.2% |
| H1 FY2026 interim dividend | 1,160 ZAc |
| Share of local broiler production | About 27% |
Astral Foods enters the close of FY2026 in its strongest financial position since its 2001 listing:
The turnaround from the FY2023 crisis, when loadshedding and the worst bird-flu outbreak on record produced a R621 m operating loss, has been decisive. It was led by Project 3R, capacity optimisation and the 2025/26 maize price collapse, and it was achieved through a CEO transition and two CFO changes.
The market has nevertheless de-rated the shares by about 25% year-to-date to about R199. At that price the stock trades on less than 5x trailing earnings and about 2.7x EV/EBITDA, with a double-digit trailing yield. That pricing implicitly assumes the current earnings run-rate is a cyclical peak, and the evidence supports caution:
-
Over FY2024–FY2025, broiler net margins averaged about 1.4%.
-
Imports are rising sharply.
-
El Niño threatens the 2026/27 maize crop.
-
The Competition Commission is scrutinising the vertical integration on which the model depends.
On balance, Astral is a high-quality operator in a structurally low-margin, highly cyclical industry. Its distinguishing features are balance-sheet resilience, scale, genetics-to-feed integration and an early lead in HPAI vaccination. These lower the probability of a repeat FY2023-type collapse, but they do not remove commodity gearing.
Even if FY2027 earnings were to halve, the shares would not look stretched on a normalised P/E of about 9–10x.
For a long-term investor, the risk-reward appears favourable at current levels on a through-the-cycle basis, with total return carried mainly by dividends. Near-term direction will depend on:
-
The tone of the FY2026 results
-
Management's capital-allocation choices for the surplus cash
-
Brazilian import volumes
-
The outcome of the 2026/27 planting season
Analyst stance: constructive on value, cautious on earnings momentum. Monitor margin normalisation closely.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles | Education | Age |
|---|---|---|---|---|---|
Gary D. Arnold | Chief Executive Officer; executive director | CEO since 1 February 2025; executive director since May 2012; with the group about 29 years | Group COO (October 2021–January 2025); MD Agriculture Division (October 2016); Director Business Development, Astral Operations (November 2010); COO Meadow Feeds Western Cape (2006); MD Provimi SSA, formerly Nutec Southern Africa (2004); Technical Manager, Meadow Feeds northern region (2001) and Delmas (1998); animal nutritionist, Meadow Feeds Delmas and Welkom (1997) | BSc Agric (Hons), MSc Agric, MBA; Pr.Sci.Nat (per third-party profile) | 54 (2026, per MarketScreener) |
Gideon Johannes (Johan) Geel | Chief Financial Officer; executive director | Since 1 March 2026 | CFO, AFGRI Limited (diversified agriculture group) | CA(SA) | — |
Henry Enslin | Financial Manager, Poultry Commercial Division (acting CFO, February 2026) | Acting CFO for one month | Financial Director, Albany Bakeries (a Tiger Brands division) | CA(SA) | — |
Leonie Marupen | Group Company Secretary | — | — | — | — |
Gideon Jordaan | Human Resources Executive | — | — | — | — |
Michael J. Schmitz | Managing Director, Feed | — | — | — | — |
“—” = not publicly disclosed.
Executive Leadership Team — Chris Schutte
| Name | Change |
|---|---|
Chris Schutte | CEO 2009–30 January 2025. Retired at the January 2025 AGM. Previously about 18 years in Tiger Brands' poultry operations. |
Daan Ferreira | CFO May 2009–2 February 2023 (retired). Joined Astral in February 2001. Acting CEO in 2020. |
Dries Ferreira | CFO and executive director 2 February 2023–31 January 2026. Resigned to join an industrial-sector company. Previously CFO of Dawn Ltd (2007), CEO of WellCapital, and CFO of Newpark REIT. |
Frans van Heerden | Executive director (from 2020) and MD, Poultry Commercial Division. |
Directors' Remuneration
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Executive directors' remuneration (ZAR Mn) | 41.0 | 76.5 | 78.2 |
Non-executive directors' fees (ZAR Mn) | 5.0 | 5.0 | 4.9 |
Prescribed officers' remuneration (ZAR Mn) | 22.3 | 34.8 | 0 |
Board of Directors
| Name | Role | Independence | Director since | Notes |
|---|---|---|---|---|
Dr Theuns Eloff | Chairman | Independent non-executive | 2007 (third-party data) | Age 68 per third-party profile (date not stated) |
D.J. Fouché | Lead independent director | Independent non-executive | — | Shown as lead independent in Profile's Stock Exchange Handbook (2024) |
Saleh Mayet | Director | Independent non-executive | 2019 (third-party data) | — |
W.F. (Willem) Potgieter | Director | Independent non-executive | 2019 (third-party data) | — |
Tshepo M. Shabangu | Director | Independent non-executive | 2013 (third-party data) | — |
Bridgitte S.M. Backman | Director | Independent non-executive | 4 September 2025 | Experience in FMCG, energy, development finance and sustainability; former UN Global Compact South Africa board member; BSc (UCT), MBA (Rotterdam School of Management) |
Alexander Muller | Director; Audit and Risk Committee member | Independent non-executive | 1 August 2026 | CA(SA); former PwC partner (2010–2019) who led governance, risk and internal audit for financial-services assurance; non-executive director of AVI Ltd and Infiniti Insurance |
Marion Shikwinya | Director; Audit and Risk Committee member | Independent non-executive | 1 August 2026 | Admitted attorney (IP, M&A, ESG); director of Mahube Infrastructure; represents the Agricultural Business Chamber on a Gauteng agri-BEE charter structure |
Gary D. Arnold | CEO | Executive | May 2012 | — |
Johan Geel | CFO | Executive | 1 March 2026 | — |
Major Shareholders
| Holder | Stake (%) | Shares | Source / date |
|---|---|---|---|
Public Investment Corporation (SOC) Ltd | 23.9 | 9,224,891 | [S19] (aggregator; date not stated). Formal notification: 26.97% on 20 February 2025 [S17]; 26.37% at 12 September 2024 [S35] |
Truffle Asset Management | 12.7 | 4,881,672 | [S19] |
Astral Operations Ltd (subsidiary; treasury shares) | 10.6 | 4,088,577 | [S19][S4] |
Mianzo Investment Management | 6.18 | 2,381,578 | [S19] |
Allan Gray (Pty) Ltd | 5.06 | 1,950,346 | [S19]. Crossed 5.07% per SENS on 8 April 2025 [S18] |
Sanlam Investment Management | 4.95 | 1,907,084 | [S19] |
The Vanguard Group | 3.99 | 1,536,558 | [S19] |
36ONE Asset Management | 2.34 | 901,367 | [S19] |
Dimensional Fund Advisors | 2.31 | 888,440 | [S19] |
Hartford Funds Management | 2.26 | 868,830 | [S19] |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | Ownership / listing | Scale indicator | Relative positioning |
|---|---|---|---|---|
Rainbow Chicken Ltd (brands: Rainbow, Farmer Brown, Simply Chicken; feed: Epol, Driehoek Feeds) | Broilers, feed | JSE (RBO); unbundled from RCL Foods 1 July 2024; Remgro historical anchor | FY June 2026 revenue R17.1 bn; about 390,000 t of chicken and about 1 Mt of feed a year; about 21% of local broiler production | #2 integrator; strong recent turnaround; EBITDA margin higher than Astral's in its latest fiscal year |
Country Bird Holdings (Supreme Poultry) | Broilers, feed | Private | About 10% of local production | #3 producer; in scope of the Competition Commission inquiry |
Sovereign Foods | Broilers | Private | About 9% of local production | #4 producer; in scope of the inquiry |
Grainfields (Grain Field Chickens) | Broilers | Private | About 5% of local production | Mid-tier producer |
Chubby Chick | Broilers | Private | About 4% of local production | Mid-tier producer |
Quantum Foods Holdings (Nova Feeds; Nulaid eggs) | Feed, broiler farming (day-old chicks, live broilers), eggs | JSE (QFH) | FY September 2025 revenue R7.15 bn (+12.9%); operating profit R361 m | Smaller, diversified; also uses Ross 308; largest egg producer in South Africa |
Brazilian exporters (e.g., BRF, JBS/Seara; illustrative) | Frozen portions, mechanically deboned meat, offal (import competition) | Foreign | Brazil supplied 84.9% of South African poultry imports in calendar 2025 (321,537 t) | Imports equal to about 26% of local consumption in H1 FY2026; pressure on tertiary and bone-in pricing |
AFGRI Animal Feeds | Feed | Private (AFGRI group) | — | Major independent feed competitor |
Independent feed mills (collectively) | Feed | Various | About 25% of the feed market per Competition Commission | Fragmented external-feed competition |
| — | Parent stock and genetics | Foreign | — | Alternative to Ross 308 for independent producers |
Serfontein Poultry (Dekalb Amberlink layer genetics) | Layer genetics (adjacent to the layer-feed market) | Private | — | Cited by the Competition Commission in its genetics market review |
“—” = not publicly disclosed.
Peer Comparison FY2025
| Metric | Astral (FY Sep-2025) | Astral (TTM to Mar-2026, derived) | Rainbow Chicken (FY Jun-2026) | Quantum Foods (FY Sep-2025) |
|---|---|---|---|---|
Revenue (ZAR Mn) | 22,619 | 23,842 | 17,100 | 7,150 |
Revenue growth (%) | 10.4 | — | 7.7 | 12.9 |
Operating margin (%) | 5.5 | 9.2 | Chicken division about 8.9 (R1.34 bn operating profit on R15.0 bn) | 5.0 |
EBITDA margin (%) | 7.0 | 10.7 | 12.5 | — |
Net profit (ZAR Mn) | 876 | 1,590 | 1340–1370 (sources differ) | — |
Local broiler production share (%) | 27 | 27 | 21 | Not in top-6 chart |
“—” = not publicly disclosed.



